Investigating how anti-inflammatory signals affect neurodegeneration in Alzheimer's disease

Anti-inflammatory signals and neurodegeneration

NIH-funded research San Diego Biomedical Research Institute · NIH-10973850

This study is looking at how certain immune signals might help protect brain cells in people with Alzheimer's disease, and it hopes to find new ways to slow down the disease by focusing on these signals.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSan Diego Biomedical Research Institute NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-10973850 on NIH RePORTER

What this research studies

This research explores the role of specific immune signals in the survival of neurons affected by Alzheimer's disease. It focuses on the interleukin-13 receptor and its impact on neuronal health, particularly in the context of neuroinflammation and oxidative stress. By studying these mechanisms in a mouse model, the research aims to uncover how these signals contribute to neurodegeneration and whether targeting them could slow down the disease process. Patients may benefit from insights that could lead to new therapeutic strategies for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related neurodegenerative conditions.

Not a fit: Patients with neurodegenerative diseases not related to Alzheimer's or those without any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow the progression of Alzheimer's disease.

How similar studies have performed: Other research has shown promise in targeting neuroinflammatory pathways for neurodegenerative diseases, suggesting potential for success in this approach.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.